Stage I noninvasive and minimally invasive uterine serous carcinoma: Comprehensive staging associated with improved survival

International Journal of Gynecological Cancer

Volumn 22, Issue 2, 2012, Pages 273-279

  Giuntoli II, Robert L ^a   Gerardi, Melissa A ^a   Yemelyanova, Anna V ^a   Ueda, Stefanie M ^b   Fleury, Aimee C ^a   Diaz Montes, Teresa P ^a   Bristow, Robert E ^c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adjuvant therapy; Surgical staging; Uterine serous carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CARCINOMA IN SITU; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; OMENTECTOMY; PELVIS LYMPHADENECTOMY; PERITONEAL BIOPSY; PREDICTIVE VALUE; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; UTERINE SEROUS CARCINOMA; UTERUS CARCINOMA;

AGED; AGED, 80 AND OVER; BALTIMORE; CYSTADENOCARCINOMA, SEROUS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; UTERINE NEOPLASMS;

EID: 84858223964     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e318238df4d     Document Type: Article

References (23)

1. Podratz KC, Mariani A. Uterine papillary serous carcinomas: the exigency for clinical trials. Gynecol Oncol. 2003;91:461-462. (Pubitemid 38388136)
2. Slomovitz BM, Burke TW, Eifel PJ, et al. Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases. Gynecol Oncol. 2003;91:463-469. (Pubitemid 38388137)
3. Kelly MG, O'Malley D, Hui P, et al. Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation. Gynecol Oncol. 2004;95:469-473.
4. Dietrich CS 3rd, Modesitt SC, DePriest PD, et al. The efficacy of adjuvant platinum-based chemotherapy in stage I uterine papillary serous carcinoma (UPSC). Gynecol Oncol. 2005;99:557-563. (Pubitemid 41686536)
5. Mehta N, Yamada SD, Rotmensch J, et al. Outcome and pattern of failure in pathologic stage I-II papillary serous carcinoma of the endometrium: implications for adjuvant radiation therapy. Int J Radiat Oncol Biol Phys. 2003;57:1004-1009. (Pubitemid 37324118)
6. Boruta DM 2nd, Gehrig PA, Fader AN, et al. Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review. Gynecol Oncol. 2009;115:142-153.
7. Fader AN, Drake RD, O'Malley DM, et al. Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma. Cancer. 2009;115:2119-2127.
8. Hamilton CA, Liou WS, Osann K, et al. Impact of adjuvant therapy on survival of patients with early-stage uterine papillary serous carcinoma. Int J Radiat Oncol Biol Phys. 2005;63:839-844. (Pubitemid 41400073)
9. Havrilesky LJ, Secord AA, Bae-Jump V, et al. Outcomes in surgical stage I uterine papillary serous carcinoma. Gynecol Oncol. 2007;105:677-682. (Pubitemid 46734192)
10. Huh WK, Powell M, Leath CA 3rd, et al. Uterine papillary serous carcinoma: comparisons of outcomes in surgical stage I patients with and without adjuvant therapy. Gynecol Oncol. 2003;91:470-475. (Pubitemid 38388138)
11. Kelly MG, O'Malley D M, Hui P, et al. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy. Gynecol Oncol. 2005;98:353-359. (Pubitemid 41169144)
12. Thomas MB, Mariani A, Cliby WA, et al. Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma. Gynecol Oncol. 2007;107:186-189. (Pubitemid 47575712)
13. Kurman RJ, Hendrick Ellenson L, Ronnett BM. Blaustein's Pathology of the Female Genital Tract. 6th ed. New York, NY: Springer; 2011.
14. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105:103-104.
15. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York, NY: Wiley; 1980.
16. McKinney WP, Young MJ, Hartz A, et al. The inexact use of Fisher's Exact Test in six major medical journals. Jama. 1989;261:3430-3433. (Pubitemid 19144711)
17. Gehrig PA, Van Le L, Fowler WC Jr. The role of omentectomy during the surgical staging of uterine serous carcinoma. Int J Gynecol Cancer. 2003;13:212-215. (Pubitemid 37055480)
18. Chan JK, Loizzi V, Youssef M, et al. Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium. Gynecol Oncol. 2003;90:181-185. (Pubitemid 37338095)
19. Walker JL, Piedmonte MR, Spirtos NM, et al. Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2. J Clin Oncol. 2009;27:5331-5336.
20. Chi DS, Abu-Rustum NR, Sonoda Y, et al. The safety and efficacy of laparoscopic surgical staging of apparent stage I ovarian and fallopian tube cancers. Am J Obstet Gynecol. 2005;192:1614-1619.
21. Ghezzi F, Cromi A, Uccella S, et al. Laparoscopy versus laparotomy for the surgical management of apparent early stage ovarian cancer. Gynecol Oncol. 2007;105:409-413. (Pubitemid 46590334)
22. Nezhat FR, Ezzati M, Chuang L, et al. Laparoscopic management of early ovarian and fallopian tube cancers: surgical and survival outcome. Am J Obstet Gynecol. 2009;200:83.e1-83.e6.
23. Park JY, Kim DY, Suh DS, et al. Comparison of laparoscopy and laparotomy in surgical staging of early-stage ovarian and fallopian tubal cancer. Ann Surg Oncol. 2008;15:2012-2019.